Form 4 for CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE
Accepted 2025-07-08 00:00:00 ET · period of report 2025-07-03 · accession 0001801170-25-000168 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-07-08 | 2025-07-03+ | CLOV | Reynoso Jamie L. | CEO, Medicare Advantage | S - Sale | $2.60 | -21.8K | 3.30M | -0.7% | -$56.8K |
| 2025-07-08 | 2025-07-03 | CLOV | Reynoso Jamie L. | CEO, Medicare Advantage | F - Tax | $2.56 | -8,706 | 3.30M | -0.3% | -$22.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-07-03 | S | D | 19,789 | $2.58 | 3,308,539 | D | — | — | (F1) The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.54 to $2.63, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| 2 | Common | Class A Common Stock | 2025-07-07 | S | D | 2,012 | $2.85 | 3,297,821 | D | — | — | (F3) The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.81 to $2.88, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| 3 | Common | Class A Common Stock | 2025-07-03 | F | D | 8,706 | $2.56 | 3,299,833 | D | — | — | (F2) Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on July 3, 2025, of 6.25% of the restricted stock units ("RSUs") granted to the Reporting Person on January 3, 2023, and originally reported on a Form 4 filed on January 5, 2023. The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring on January 3, 2027, in each case subject to the continued service of the Reporting Person on each such vesting date. |